Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Afeyan Noubar
Relationship:   Director, 10% Owner
City:   Lexington
State:   MA
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   8,055,025    

Indirect Shares

   111,880,829      
Direct Value   $19,713,716    

Indirect Value

   $89,988,676      
Total Shares   119,935,854      
Total Value   $109,702,391      


Color Kinetics Inc $0 Receptos, Inc. $0 Editas Medicine, Inc. $19,702,352 Seres Therapeutics, Inc. $11,363 Moderna, Inc. $0 Color Kinetics Inc $0 Receptos, Inc. $0 Editas Medicine, Inc. $19,702,352 Seres Therapeutics, Inc. $11,363 Moderna, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    10   
    0    

     Stock price went up :
    3   
    0    
     Stock price went down :
    7   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   -22.5%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Color Kinetics Inc CLRK Director 2005-10-03 83,062 2005-10-03 12,000    Premium*  
            Agenus Inc AGEN Director 2006-12-14 0 2006-12-14 0    Premium*  
            Helicos Biosciences Corp HLCSQ Director, 10% Owner 2009-09-18 0 2009-09-18 12,192,640    Premium*  
            Receptos, Inc. RCPT 10% Owner 2013-11-18 1,693,551 0    Premium*  
            DNIB Upwind Inc BIND Director, 10% Owner 2013-09-25 0 2013-09-25 1,562,616    Premium*  
            Bg Medicine, Inc. BGMD Director, 10% Owner 2015-12-09 0 2015-12-09 1,286,274    Premium*  
            Editas Medicine, Inc. EDIT 10% Owner 2016-02-08 3,964,256 2016-02-08 991,060    Premium*  
            Selecta Biosciences Inc SELB 10% Owner 2016-06-27 0 2016-06-27 1,651,862    Premium*  
            Kaleido Biosciences, Inc. KLDO 10% Owner 0 2021-02-08 14,907,627    Premium*  
            Transmedics Group, Inc. TMDX 10% Owner 0 2019-10-29 120,595    Premium*  
            Seres Therapeutics, Inc. MCRB 10% Owner 2019-06-18 15,141 2022-07-05 17,617,352    Premium*  
            Moderna, Inc. MRNA 2024-06-18 2,299,015 2024-06-18 4,632,149    Premium*  
            Axcella Health Inc. AXLA 10% Owner 2020-05-18 0 2022-10-13 8,850,296    Premium*  
            Evelo Biosciences Inc EVLO 2020-06-29 0 2023-07-11 4,977,588    Premium*  
            Codiak Biosciences, Inc. CDAK 10% Owner 0 2022-09-15 1,674,869    Premium*  
            Foghorn Therapeutics Inc. FHTX 10% Owner 2020-10-27 0 2020-10-27 1,851,801    Premium*  
            Sigilon Therapeutics, Inc. SGTX 10% Owner 2020-12-08 0 2023-08-11 0    Premium*  
            Sana Biotechnology, Inc. SANA 10% Owner 2021-02-08 0 2023-09-13 581,695    Premium*  
            Rubius Therapeutics, Inc. RUBY Director, 10% Owner 2021-03-19 0 2021-03-19 17,253,519    Premium*  
            Omega Therapeutics, Inc. OMGA Director, 10% Owner 2021-08-03 0 2023-02-27 21,716,886    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
TMDX Transmedics Group, Inc. 10% Owner   –       –       •   2019-05-01 3 IO $0.00 $0 I/I 0 483,021 -
TMDX Transmedics Group, Inc. 10% Owner   –       –       •   2019-05-06 4 A $0.00 $0 I/I 483,021 268,736 0 -
TMDX Transmedics Group, Inc. 10% Owner   –       –       •   2019-05-06 4 D $0.00 $0 I/I (1,690,579) 0 0 -
TMDX Transmedics Group, Inc. 10% Owner   –       –       •   2019-05-06 4 A $0.00 $0 I/I 2,047,254 1,061,102 0 -
TMDX Transmedics Group, Inc. 10% Owner   –       –       •   2019-10-29 4 D $0.00 $0 I/I (2,840,191) 0 0 -
SGTX Sigilon Therapeutics, Inc... 10% Owner   –       –       •   2020-12-08 4 A $0.00 $0 I/I 10,370,369 1,481,481 0 -
SGTX Sigilon Therapeutics, Inc... 10% Owner   –       –       •   2023-08-11 4 D $14.92 $11,901,982 I/I (797,720) 0 0 -
MCRB Seres Therapeutics, Inc. Director   –       •       •   2019-06-18 4 B $2.25 $19,999,998 I/I 8,888,888 4,444,444 2.25 -
MCRB Seres Therapeutics, Inc. 10% Owner   –       –       •   2020-11-23 4 D $0.00 $0 I/I (7,907,179) 0 0 -
MCRB Seres Therapeutics, Inc. 10% Owner   –       –       •   2021-05-17 4 D $0.00 $0 I/I (295,171) 2,962,963 0 -
MCRB Seres Therapeutics, Inc. 10% Owner   –       –       •   2022-07-05 4 B $3.15 $27,525,465 I/I 8,738,243 5,825,495 1.5 %
SELB Selecta Biosciences Inc 10% Owner   –       –       •   2016-06-27 4 A $0.00 $0 I/I 1,620,747 1,651,862 0 -
SANA Sana Biotechnology, Inc. 10% Owner   –       –       •   2021-02-08 4 A $0.00 $0 I/I 34,239,018 11,585,199 0 -
SANA Sana Biotechnology, Inc. 10% Owner   –       –       •   2023-05-24 4 S $6.57 $2,283,836 I/I (347,870) 1,447,791 0 -
SANA Sana Biotechnology, Inc. 10% Owner   –       –       •   2023-05-25 4 S $6.35 $732,866 I/I (115,372) 1,434,664 0 -
SANA Sana Biotechnology, Inc. 10% Owner   –       –       •   2023-05-26 4 S $6.23 $510,573 I/I (82,000) 1,425,334 0 -
SANA Sana Biotechnology, Inc. 10% Owner   –       –       •   2023-06-06 4 S $6.31 $1,284,918 I/I (203,758) 1,403,037 0 -
SANA Sana Biotechnology, Inc. 10% Owner   –       –       •   2023-06-07 4 S $6.24 $1,247,940 I/I (200,000) 1,380,277 0 -
SANA Sana Biotechnology, Inc. 10% Owner   –       –       •   2023-09-13 4 D $0.00 $0 I/I (11,781,275) 0 0 -
RUBY Rubius Therapeutics, Inc. Director   –       •       •   2021-03-19 4 B $29.00 $6,090,000 I/I 210,000 2,633,703 2.25 %
RCPT Receptos, Inc. 10% Owner   –       –       •   2013-05-08 3 IO $0.00 $0 D/D 0 114,285 -
RCPT Receptos, Inc. 10% Owner   –       –       •   2013-05-14 4 B $14.00 $1,499,988 D/D 107,142 1,924,339 2.45 -
RCPT Receptos, Inc. 10% Owner   –       –       •   2013-05-14 4 OE $5.25 $10,306,453 D/D 1,702,912 1,817,197 0 -
RCPT Receptos, Inc. 10% Owner   –       –       •   2013-11-14 4 S $25.03 $3,894,242 D/D (155,583) 1,768,755 0 -
RCPT Receptos, Inc. 10% Owner   –       –       •   2013-11-15 4 S $24.20 $1,329,490 D/D (54,904) 1,713,851 0 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us